Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

IRWD

IRONWOOD PHARMACEUTICALS INC

Pharmaceutical Preparations · SIC 2834CIK 1446847Held by 3 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$296.0M
Net Income FY2025
$24.0M
EPS (Basic, as reported)
$0.15
Net Margin FY2025
8.1%
ROE FY2025
-9.2%
Total Equity
$(262.0M)
Shares Out
165M
Business description

IRONWOOD PHARMACEUTICALS INC — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2009–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 274 → 296 +0.9% CAGR
Fiscal yearFY2016FY2017⚑FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue274298347428390414411443351296
Cost of revenue(2)(19)(33)(24)(3)—————
Research & development(139)(148)(167)(115)(88)(70)(44)(116)(111)(95)
Selling, general & administrative(173)(233)(241)(172)(140)(111)(116)(158)(144)(82)
General & administrative——————————
Total operating expenses(326)(376)(586)(308)(247)(181)(160)(1,388)(258)(198)
Operating income(52)(77)(239)120143232250(945)9399
Interest expense(39)(36)(38)(37)(29)(31)(8)(22)(33)(33)
Interest & investment income——————————
Other income (expense), net(30)(40)(43)(61)(34)(32)2(3)(28)(28)
Pre-tax income——(194)59109201252(948)6570
Income tax expense0000(3)(328)(77)(83)(64)(46)
Net income(82)(117)(282)22106528175(1,002)124
EPS — basic——($1.85)$0.14$0.67$3.26$1.13($6.45)$0.01$0.15
EPS — diluted——($1.85)$0.14$0.66$3.21$0.96($6.45)$0.01$0.15
Shares outstanding — basic (M)——153156159162154155159162
Shares outstanding — diluted (M)——153156161164186155160163

Showing the latest 10 of 17 fiscal years.

  • ⚑ Weighted-average shares changed ×1.53 between FY2011 and FY2018 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.